- Through the new partnership PDCO will sell the full line of ABAX veterinary diagnostic products, including external reference lab services and in-clinic testing.
- The agreement will further PDCO’s goal of providing a comprehensive suite of diagnostic solutions and technical support to the veterinary community.
- The strengthening of PDCO’s veterinary division may be a prelude to the sale or spin-off of their reimbursement pressured medical rehabilitation division.
- The company’s substantial share buybacks and steady dividend increases reward the company’s shareholders as the company transforms.
- We did not anticipate PDCO’s new partnership but did recognize the veterinary market is facing favorable trends and that the company will continue to capitalize on those trends.